Prevalence and predictors of depressive symptoms and wellbeing during and up to nine years after outpatient cardiac rehabilitation

Swiss Medical Weekly

Volumn 141, Issue JULY, 2011, Pages

  Koçer, Oezlem ^a   Wachter, Matthias ^a   Zellweger, Michael J ^a   Piazzalonga, Simone ^a   Hoffmann, Andreas ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Cardiac rehabilitation; Depression; Late follow up

Indexed keywords

ADULT; AGED; ARTICLE; DEPRESSION; DIABETES MELLITUS; EXERCISE; FEMALE; FOLLOW UP; HEART REHABILITATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MOOD CHANGE; OUTCOME ASSESSMENT; OUTPATIENT; OUTPATIENT CARDIAC REHABILITATION; PREDICTOR VARIABLE; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; SMOKING; TREATMENT DURATION; WELLBEING; AFFECT; EXERCISE TOLERANCE; HEALTH STATUS; HEART DISEASE; KINESIOTHERAPY; MIDDLE AGED; PSYCHOLOGICAL ASPECT; RISK FACTOR; STATISTICAL MODEL;

AFFECT; AGED; DEPRESSION; DIABETES MELLITUS; EXERCISE THERAPY; EXERCISE TOLERANCE; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HEART DISEASES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; SMOKING;

EID: 80052204940     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: 10.4414/smw.2011.13242     Document Type: Article

References (30)

1. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction: impact on 6-month survival. JAMA. 1993;270:1819-25. (Pubitemid 23301435)
2. Forrester AW, Lipsey JR, Teitelbaum ML, De Paulo JR, Andrzejewski PL. Depression following myocardial infarction. Int J Psychiatrie Med. 1992;22:33-46.
3. Binder RK, Barth J, Schmid JP, Saner H. Burden of abdominal obesity in cardiac rehabilitation patients. Swiss Med Wkly. 2011;141:w13153
4. Kemo DE, Malhotra S, Franco KN, Tesar G, Bronson DL. Heart disease and depression: dont ignore the relationship. Cleve Clin J Med. 2003;70:745-6, 749-50, 752-4 passim.
5. Bush DE, Ziegelstein RC, Tayback M, et al. Even minimal symptoms of depression increase mortality risk after acute myokardial infarction. Am J Cardiol. 2001;88:337-41. (Pubitemid 32823291)
6. Zellweger MJ. Coronary artery disease and depression. Eur Heart J. 2004;25:3-9. (Pubitemid 38055586)
7. Swaab DF, Bao AM, Lucassen PJ. The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev. 2005;4:141-94. (Pubitemid 41114861)
8. Boudarene M, Legros JJ, Timsit-Berthier M. Study of the stress response: role of anxiety, cortisol and DHEAs. Encephale. 2002;28:139-46. (Pubitemid 34632646)
9. Meaney MJ, Dioro J, Francis D, Widdowson J, LaPlante P, Caldji C, et al. Early environmental regulation of forebrain glucocorticoid receptor gene expression: implications for adrenocortical responses to stress. Dev Neurosci. 1996;18:49-72. (Pubitemid 26257908)
10. Lynch D, Tamburino M, Nagel R. Depressive Symptoms: associations with health perceptions and health behaviors. Department of Family Medicine, Medical College of Ohio, Toledo, USA 1996;4:68-72.
11. Rozanski A, Blumenthal JA, Kaplan J. Impact of Psychological Factors on the Pathogenesis of Cardiovascular Disease and Implications for Therapy. Circulation.1999;99:2192-217. (Pubitemid 29196806)
12. Pfiffner D, Hoffmann A. Psychosocial Predictors of Death for Low-Risk Patients After a First Myocardial Infarction: A 7-year follow-up study. J Cardiopulm Rehabil. 2004;24:87-93. (Pubitemid 38437127)
13. Smith OR, Pedersen SS, Van Domburg RT, Denollet J. Symptoms of fatigue and depression in ischemic heart disease are driven by personality characteristics rather than disease stage: a comparison of CAD and CHF patients. Eur J Cardiovasc Prev Rehabil. 2008;15:583-8.
14. Jeger RV, Jörg L, Rickenbacher P, Pfisterer ME, Hoffmann A. Benefit of outpatient cardiac rehabilitation in underpresented patient subgroups. J Rehabil Med. 2007;39:246-51.
15. Siegrist J, Broer M, Junge A. Profil der Lebensqualität Chronisch kranker (PLC). Göttingen: Hogrefe Verlag; 1996.
16. Laubach W, Schröder C, Siegrist J, Brähler E. Normierung der Skalen «Profil der Lebensqualität Chronisch Kranker» an einer repräsentativen deutschen Stichprobe. Zeitschrift für Differentielle und Diagnostische Psychologie 2001;104:2996-3007.
17. Arrol B, Khin N, Kerse N, Auckland, New Zealand. Screening for depression in primary care with two verbally asked questions: cross sectional study. BMJ. 2003;327:1144-6. (Pubitemid 37421811)
18. Birkel-Smith M, Hansen BH, Hanash JA, Hansen JF, Rasmussen A. Mental disorders and general well-being in cardiology outpatients - 6-year survival. J Psychosom Res. 2009;67:5-10. Epub 2009 Mar 5.
19. Angst J. The epidemiology of depressive disorders. Europ Neuropsychopharmacology 1995;Suppl 95-8. (Pubitemid 26022217)
20. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depession, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007;370:851-8. (Pubitemid 47362344)
21. Batra A, Collins SE, Torchalla I, Schröter M, Buchkremer G. Multidimensional smoker profiles and their prediction of smoking following a pharmacobehavioral intervention. J Subst Abuse Treat. 2008;35 (1):41-52 Epub 2007 Oct.10 (Pubitemid 351736019)
22. Vieyra-Reyes P, Venebra-MunozA, Rivas-Santiago B, Garcia-Garcia F. Nicotine as an antidepressant and regulator of sleep in subjects with depression. Rev Neurol. 2009;49:661-7.
23. Salin-Pascual RJ, Rosas M, Jimenz-Genchi A, Rivera-Meza BL, Delgado-Parra V. Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression. J Clin Psychiatry. 1996;57:387-9. (Pubitemid 26321988)
24. Mineur YS, Picciotto M. Biological basis for the co-morbidity between smoking and mood disorder. J Dual Diagn. 2009;122-30.
25. Hirsch RD, Junglas K, Kontadt B, Jonnitz MF. Humor therapy in the depressed elderly: Results of an empirical study. Z Gerontol Geriatr. 2010;43:42-52.
26. Trivedi MH, Pigotti TA, Perera P Dillingham KE, Carfagno ML, Pitts CD. Effectiveness of low doses of paroxetine controlled release in the treatment of major depression disorder. J Clin Psychiatry. 2004;65:1356-64.
27. Fournier JC, DeRubeis, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, et al. Antidepressant drug effects and depression severity: a patient level meta-analysis. JAMA. 2010,6;303:47-53.
28. Scott J. Cognitive therapy of affektive disorder: a review. J Affect Disord. 1996;12;37:1-11. (Pubitemid 26072811)
29. Coxtall JD, Scott LJ. Olanzapine/ Fluoxetine: a review of its use in patients with treatment-resistant major depressive disorder. CNS Drugs. 2010 1;24:245-62. doi:10.2165/112038-000000000-00000
30. DeRubeis RJ, Siegle GJ, Hollon SD. Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms. Nat Rev Neurosci. 2008;9:788-96. Epub 2008 Sep 11.